New drug for Macular Degeneration

Genetech is currently studying a new drug, lampalizumab, to treat age-related macular degeneration. The drug is designed to slow the destruction of light-sensing cells in the retina. When those cells die, they are unable to regenerate, which causes permanent vision loss. 129 patients participated in the 18-month study and received monthly eye injections. The patients […]

Lutein levels in the eye linked to higher achievement in children

Two recent studies demonstrated that children who do better in school have higher lutein levels in the eye. Even after taking in consideration other factors including IQ, gender, body composition and physical fitness, children that had higher lutein levels did better on cognition tests and performed better academically. In the first study, researchers measured lutein […]

Macular Degeneration affects mental health too

The National Eye Institute recently conducted a study that found that patients with low vision are twice as likely as the blind to suffer from depression and five times more likely than the normal population to suffer from depression. The study involved mental health professionals and eye care professionals who sought to determine the cause […]

Optometrists more likely than ophthalmologists to recommend eye supplements

A recent study was conducted among Swedish optometrists and ophthalmologists that examined use of nutritional supplements, dietary advice, smoking and eye diseases and strength of evidence and the sources of information used for supplement recommendations. Optometrists responded at a much higher rate to the questionnaire used in the study at a rate of 40.3% compared […]

Will eyedrops replace injections for Macular Degeneration?

Researchers at the University of Birmingham have created a new eyedrop that can deliver wet macular degeneration treatment to the back of the eye. Macular degeneration causes damage to the retina at the back of the eye so this is why it is necessary for the medication to be focused on that area rather than […]

Eye disease screening recommendations

Adults who have no signs or risk factors for eye disease should get a baseline eye disease screening at age 40 according to recommendations by the American Academy of Ophthalmology. Age 40 is the age when early signs of eye disease and vision changes might begin to occur. The baseline screening will allow the ophthalmologist […]

Eye care providers not always detecting AMD

A recent study found that many times, primary eye care providers are missing cases of age-related macular degeneration. After reviewing data on 1,288 eyes in patients who received a dilated eye exam and who were not diagnosed with macular degeneration, researchers had retina specialists take another look and macular degeneration was diagnosed in 25 percent […]

Discontinuing macular degeneration injections results in vision loss

A retrospective, observational study examined the data from 35 patients who had received anti-VEGF injections of the eye for treatment of the wet form of macular degeneration but then stopped treatment despite continued symptoms. Researchers found a notable deterioration in visual acuity over two years. Researchers looked at the best-corrected visual acuity (BCVA) at the […]

Doctors successful retinal stem cell treatment

Doctors successfully transplanted retinal stem cells from a donor to the recipient in the first ever surgery of its type. Previously, doctors had performed a retinal stem cell┬átransplant back in 2014 using that patient’s own skin cells that were reprogrammed. That procedure was considered a success after a year with no decline in the patient’s […]

Not keeping up with your eye vitamins?

Keeping pace with your macular degeneration eye vitamins every day can be a challenge. I know, because while 90% of my own patients take them twice daily, every day, about one in ten people struggle to keep up. And each time an autoship customer tells us to delay a shipment because they “have too many […]